zohman
Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients
The National Institute for Health and Care Excellence (NICE) in the UK has published a positive draf...
Alvimedica announces CE mark for Cre8 Evo 2mm
Alvimedica has announced the company has received the CE mark for the Cre8 Evo 2mm, a polymer-free A...
Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel devices
Experts from the Society for Cardiovascular Angiography and Interventions (SCAI) have reviewed the r...
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead o...
Analysis of LAA closure devices reveals post-approval spike in safety events
A retrospective study conducting a safety assessment and comparison between two percut...
